Filter
595
Filtered Results: 595
Text search:
the
Essential
Drugs
Programme,
the
PHC
Featured
Recommendations
53
New Publications
245
Language
Document type
No document type
430
Guidelines
54
Studies & Reports
45
Strategic & Response Plan
29
Manuals
24
Training Material
6
Situation Updates
2
Infographics
2
Fact sheets
2
Online Courses
1
Countries / Regions
India
113
Nigeria
44
South Africa
39
Nepal
36
Uganda
23
Ethiopia
21
Sierra Leone
19
Kenya
15
Zambia
13
Bangladesh
13
Namibia
12
Global
12
Liberia
10
Lesotho
10
Malawi
9
Botswana
9
Ghana
7
Western and Central Europe
7
Syria
6
Tanzania
6
Myanmar / Burma
6
East and Southern Africa
6
Ukraine
5
Eastern Europe
5
Cambodia
4
Mozambique
4
Latin America and the Carribbean
4
Africa
4
Laos
4
West and Central Africa
3
South–East Asia Region
3
Cameroon
2
Zimbabwe
2
Pakistan
2
South Sudan
2
Rwanda
2
Eswatini/ Swaziland
2
Sri Lanka
2
Middle East and North Africa
2
Albania
2
Russia
2
Moldova
2
Vietnam
2
Haiti
1
Philippines
1
Somalia
1
Afghanistan
1
Germany
1
Lebanon
1
Chad
1
Thailand
1
Indonesia
1
Benin
1
Central African Republic
1
Brazil
1
Libya
1
Asia
1
Bhutan
1
Armenia
1
Southern Africa
1
Tajikistan
1
Georgia
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
399
Public Health
44
Clinical Guidelines
29
Women & Child Health
17
Key Resources
11
Capacity Building
7
Pharmacy & Technologies
1
Toolboxes
TB
49
Mental Health
29
HIV
24
COVID-19
20
Caregiver
19
NCDs
14
NTDs
10
Disability
9
Conflict
9
Refugee
6
AMR
6
Pharmacy
6
Global Health Education
5
Rapid Response
4
Health Financing Toolbox
4
Natural Hazards
3
Planetary Health
3
Polio
2
Ebola
1
Specific Hazards
1
Social Ethics
1
The revised package of BFHI materials includes five sections: 1. Background and Implementation, 2. Strengthening and Sustaining the BFHI: A course for decision-makers, 3. Breastfeeding Promotion and...
The document is primarily meant to inform mental health and psychosocial support (MHPSS) staff, such as: psychologists, psychosocial counsellors, social workers, psychiatrists, psychiatric nurses, and others who are involved providing individual or ...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines ... effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines ... effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
(Health Systems in Transition, Vol. 4, No. 3, 2014)
Lancet 2022; 399: 1155–200 Published Online March 15, 2022 https://doi.org/10.1016/
S0140-6736(21)02488-0
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epi...
The workshop aimed to support countries in the prioritization and acceleration of NCD prevention and management with a specific focus on accelerating the<...
